Strides Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?
STRIDES PHARMA has two hundred and forty-five approved drugs.
There are three tentative approvals on STRIDES PHARMA drugs.
Summary for Strides Pharma
US Patents: | 0 |
Tradenames: | 153 |
Ingredients: | 149 |
NDAs: | 245 |
Patent Litigation for Strides Pharma: | See patent lawsuits for Strides Pharma |
Drugs and US Patents for Strides Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Strides Pharma | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET;ORAL | 202702-004 | Jun 3, 2014 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Strides Pharma | FUROSEMIDE | furosemide | TABLET;ORAL | 018415-002 | Jul 27, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Strides Pharma | ETHOSUXIMIDE | ethosuximide | CAPSULE;ORAL | 211928-001 | Feb 19, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Strides Pharma | MEPERIDINE HYDROCHLORIDE | meperidine hydrochloride | TABLET;ORAL | 040191-002 | Dec 17, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Strides Pharma | ATENOLOL | atenolol | TABLET;ORAL | 074099-001 | Apr 28, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Strides Pharma | GLYBURIDE (MICRONIZED) | glyburide | TABLET;ORAL | 074591-002 | Dec 22, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Strides Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-007 | Jun 13, 1995 | 4,105,776 | ⤷ Try a Trial |
Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-001 | Approved Prior to Jan 1, 1982 | 5,238,924 | ⤷ Try a Trial |
Strides Pharma | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-003 | Sep 17, 1999 | 6,143,775 | ⤷ Try a Trial |
Strides Pharma | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-003 | Sep 17, 1999 | 5,583,152 | ⤷ Try a Trial |
Strides Pharma | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-003 | Sep 17, 1999 | 4,859,692 | ⤷ Try a Trial |
Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-007 | Jun 13, 1995 | 4,215,104 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for STRIDES PHARMA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
➤ Subscribe | Tablets | 10 mg and 20 mg | ➤ Subscribe | 2008-02-29 |
Similar Applicant Names
Here is a list of applicants with similar names.